Physician

Alex Jesus Manzano, M.D.

According to 2025 Medicare claims, Alex Manzano, M.D. (NPI: 1356523633) practices endocrinology in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is ANDREINA ROJAS MD PA (NPI: 1720517535; TIN: 81-5070490) and primary practice location at 33140-2891. Manzano is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Manzano's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 396 traditional Medicare patients, billed 1,179 HCPCS/CPT codes, and received $100,239 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,494 prescription claims across 685 beneficiaries totaling $2,531,299 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 439 claims. Open Payments data shows 165 records totaling $23,451. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $264,197 to $2,531,299. For DME billing, reported payments moved sharply higher in recent years, from $2,003 to $172,804.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	359	1,314	$130,741
2016	402	1,324	$123,581
2017	457	1,329	$124,991
2018	494	1,413	$123,744
2019	521	1,392	$124,772
2020	395	849	$65,560
2021	210	399	$40,805
2022	308	778	$75,144
2023	362	1,183	$101,481
2024	396	1,179	$100,239

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	162	902	$264,197
2016	237	1,312	$444,394
2017	273	1,697	$587,489
2018	343	2,174	$829,375
2019	388	2,600	$1,109,286
2020	463	2,848	$1,291,842
2021	454	2,836	$1,433,407
2022	505	3,430	$1,664,315
2023	618	4,469	$2,784,980
2024	685	4,494	$2,531,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	49	109	$1,830
2016	129	332	$4,606
2017	136	320	$7,108
2018	212	590	$38,279
2019	221	776	$90,121
2020	162	794	$123,659
2021	123	660	$121,111
2022	115	768	$184,282
2023	114	759	$138,747
2024	111	439	$170,961

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	121	121	$132
10005	Fine needle aspiration biopsy using ultrasound guidance, first growth	14	14	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	324	723	$96
76536	Ultrasound scan of head and neck soft tissue	30	45	$54
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	87	220	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	443	14,187	$523,758
Ozempic	Semaglutide	399	14,072	$465,022
Jardiance	Empagliflozin	228	12,237	$241,266
Rybelsus	Semaglutide	143	5,790	$183,110
Trulicity	Dulaglutide	130	4,412	$148,480

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	77	330	$157,669
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	24	$5,899
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	18	18	$4,079
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	11	$2,535
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	16	39	$753

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	165	$23,451	Insulet Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alex Jesus Manzano, M.D.?

Tedicare shows public-source Medicare data for Alex Jesus Manzano, M.D. (NPI 1356523633), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alex Jesus Manzano, M.D. have ACO affiliation data?

Alex Jesus Manzano, M.D. is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Alex Jesus Manzano, M.D.?

Alex Jesus Manzano, M.D. is linked to ANDREINA ROJAS MD PA (billing NPI 1720517535) in the available physician profile data.

Does Alex Jesus Manzano, M.D. have Open Payments data?

Alex Jesus Manzano, M.D. has 165 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.